395 METHYLENE BLUE MMX® INCREASES ADENOMA DETECTION RATE IN SCREENING AND SURVEILLANCE COLONOSCOPY- A MULTI-CENTRE, MULTINATIONAL, PLACEBO CONTROLLED, RANDOMISED, DOUBLE-BLIND AT RANDOMISATION, PARALLEL-GROUP, PHASE III STUDY

Autor:	Michael B. Wallace, Peter D. Siersema, Norman E. Marcon, Franco Radaelli, Ralf Kiesslich, Matthew D. Rutter, Cesare Hassan, Francisco C. Ramirez, Manon C.W. Spaander, Evelien Dekker, Raf Bisschops, Renato Cannizzaro, Alessandro Repici, Michele A. Young, David H. Bruining, Pradeep Bhandari, David Gatof, James E. East, Marcia I. Canto, Michael Vieth, Prateek Sharma, Limas Kupčinskas
Rok vydání:	2018
Předmět:	medicine.medical_specialty Adenoma business.industry Gastroenterology Placebo medicine.disease Surgery Double blind chemistry.chemical_compound chemistry medicine Radiology Nuclear Medicine and imaging Surveillance colonoscopy Detection rate Multi centre business Methylene blue MMX
Zdroj:	Gastrointestinal Endoscopy. 87:AB74
ISSN:	0016-5107
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f3b77c76924f582cd2fee953f2c81035 https://doi.org/10.1016/j.gie.2018.04.063 Zobrazit plný text záznamu Full Text from ScienceDirect